Author

Shi Xu

AbbVie (United States)ORCID 0000-0002-2178-5666Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Shi Xu2 papers

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Hin Ching LoiD· 1 shared Jacob PfeiliD· 1 shared Josue A. SamayoaiD· 1 shared Kyle D. HalliwilliD· 1 shared Liqian MaiD· 1 shared Robert T. McLaughliniD· 1 shared Severiano Villarruel· 1 shared Stephen Wilson· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Hin Ching LoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

tauX: A Gene Expression Ratio Strategy to Improve Machine Learning Applications in Precision Medicine

Jacob Pfeil, Liqian Ma, Hin Ching Lo, Tolga Turan, Robert T. McLaughlin, Shi Xu, Severiano Villarruel, Stephen Wilson, Xi Zhao, Josue A. Samayoa, Kyle D. Halliwill

The paper introduces tauX, a gene expression ratio strategy that improves machine learning performance in precision medicine by refining gene expression features.

bioRxiv · Jul 1, 2024 · PreprintBioinformatics